Senior Editor, Diagnostic Imaging
What a New MRI Study Reveals About Brain Aging and Racial Disparities
November 17th 2022New magnetic resonance imaging research shows earlier brain aging in middle-age Black individuals with researchers suggesting that cumulative exposure to stress over socioeconomic and environmental adversities may be a key contributing factor.
SPECT Imaging Agent Gets Expanded FDA Approval for Patients with Suspected Dementia with Lewy Bodies
November 16th 2022GE Healthcare’s DaTscan is reportedly the first radiopharmaceutical tracer agent approved by the Food and Drug Administration (FDA) for use in patients with suspected dementia with Lewy bodies.
Chest CT Study Suggests Marijuana Smokers May Have Higher Emphysema Risk Than Tobacco-Only Smokers
November 15th 2022A new computed tomography study reveals that people who smoke marijuana may have a 70 percent higher risk of developing emphysema than non-smokers, and an age-matched subgroup analysis suggests marijuana use could be associated with a 26 percent higher risk of emphysema in comparison to tobacco-only smoking.
New MRI Study Identifies Signature White Matter Connectivity Patterns in People with Autism
November 14th 2022Emerging research has revealed findings on diffusion magnetic resonance imaging (MRI) correlational tractography that may help neuroradiologists differentiate between autism spectrum disorder (ASD) and developmental coordination disorder (DCD).
Emergency Department Radiology: Study Shows Higher Imaging Orders by NPPs
November 11th 2022A new study of nearly 17 million emergency department (ED) visits by Medicare beneficiaries between 2005 and 2020 revealed the presence of non-physician practitioners (NPPs) was associated with a 5.3 percent increase in imaging.
Emerging PET/CT Imaging Agent Shows Promise for Diagnosing Clear Cell Renal Cell Carcinoma
November 10th 2022Findings from a recent multinational phase III trial demonstrated that the investigational agent TLX250-CDx had an 86 percent sensitivity rate for detecting clear cell renal cell carcinoma via positron emission tomography/computed tomography (PET/CT).
Seven Takeaways from Lung-RADS 2022 for CT Lung Cancer Screening
November 10th 2022In the newly released Lung-RADS 2022 classification system for computed tomography (CT) lung cancer screening, the American College of Radiology (ACR) has noted a variety of updates including new classification criteria for atypical pulmonary cysts and airway nodules, time intervals for nodule growth and a new stepped management approach for Lung-RADS categories 3 and 4A.
New Computed Tomography System Offers Potential Benefits in Cardiac Imaging
November 9th 2022The recently launched Scenaria View Focus Edition computed tomography (CT) system features an advanced cardiac motion correction tool that reportedly provides significantly higher temporal resolution than conventional image reconstruction.
Current Insights on AI, Breast Cancer Screening and the FDA
November 8th 2022In a recently published article, researchers from Yale University discuss the pros and cons of current FDA regulations as they apply to the clearance and use of adjunctive artificial intelligence (AI) software with conventional breast cancer screening modalities such as mammography.
Study Shows Less Than 50 Percent Adherence to Follow-Up After Positive CT Findings for Lung Cancer
November 4th 2022In a multicenter study of 685 people who had positive findings for lung cancer on low-dose computed tomography (CT), researchers found that men, Black individuals, and smokers had lower rates of adherence with recommended follow-up care.
Is CT Overutilized in the ER for Suspected Urinary Stone Disease?
November 1st 2022Reviewing data from over 4 million patients who presented to emergency departments with suspected urinary stone disease between 2012 and 2018, researchers noted a greater than 10 percent decrease in visits with no imaging study and a greater than 10 percent increase in visits with CT imaging.
New Software Facilitates Use of Coronary CT Angiography Scans in Radiology Workflow
November 1st 2022Emphasizing ease of installation and a cloud-based service, Cleerly said its new Proxy software allows smooth transmission of coronary computed tomography angiography (CCTA) scans between interdisciplinary clinicians caring for patients with heart disease.
Deep Learning Improves CT Guidance for Revascularization of Coronary Total Occlusions
October 31st 2022Emerging research revealed that a deep learning model had a nearly twofold increase in successful segmentation and reconstruction of coronary total occlusions (CTOs) on coronary computed tomography angiogram (CCTA) and a 73 percent reduction in post-processing and measurement time in comparison to a conventional manual approach.
Radiotherapy for Prostate Cancer: Study Says MRI Guidance Significantly Reduces GU and GI Toxicities
October 28th 2022For patients undergoing stereotactic body radiotherapy (SBRT) for prostate cancer, the acute genitourinary (GU) toxicity rate associated with the procedure was 19 percent lower with magnetic resonance imaging (MRI) guidance in comparison to computed tomography (CT) guidance, according to new research presented recently at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Can AI-Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital Mammography?
October 27th 2022In separate test sets of Israeli women and United States women who had either ductal carcinoma in situ or invasive breast cancer, emerging artificial intelligence (AI) algorithms achieved an area under the curve (AOC) of 88 percent and 80 percent, respectively, for malignancy detection.
Transvaginal Ultrasound or MRI: Which is More Effective in Evaluating Endometrial Cancer?
October 26th 2022In a new study looking at pre-operative assessment of low-grade endometrial cancer, researchers found that while magnetic resonance imaging (MRI) had 20 percent higher specificity than transvaginal ultrasound for deep myometrial invasion, there was no difference in sensitivity.
Could an Emerging PSMA/PET Imaging Agent Improve the Detection of Recurrent Prostate Cancer?
October 25th 2022In a recent video interview from the American Society for Radiation Oncology (ASTRO) Annual Meeting, Benjamin Lowentritt, MD discussed the challenges of conventional imaging in diagnosing prostate cancer recurrence and the potential of an emerging high affinity, radiohybrid prostate-specific membrane antigen/positron emission tomography (PSMA/PET) imaging agent.
Study Suggests Shorter Duration of Radiation Therapy is Effective for High-Risk Prostate Cancer
October 24th 2022Five weeks of radiation therapy is just as effective as eight weeks of radiation treatment for men with high-risk prostate cancer, according to new research presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Philips Gets FDA Nod for MRI Head and Neck Radiotherapy Application
October 20th 2022For physicians performing radiotherapy treatment of soft tissue tumors in the head and neck, the MRCAT Head and Neck offers an artificial intelligence (AI) application that allows the use of magnetic resonance imaging (MRI) as the primary or sole imaging for procedure planning.
HeartFlow Garners FDA Clearances for Two AI-Powered Assessment Tools with CCTA
October 20th 2022Plaque Analysis and RoadMap Analysis, two artificial intelligence (AI)-enabled assessment products, may enhance clinical evaluation of coronary artery disease (CAD) on cardiac computed tomography angiography (CCTA).